Intensity of end-of-life cancer care among seniors: Variations by principal health care provider.

Authors

null

K. Murray

Center for Outcomes Research and Evaluation, Maine Medical Center, Portland, ME

K. Murray , L. Lucas , S. Miesfeldt

Organizations

Center for Outcomes Research and Evaluation, Maine Medical Center, Portland, ME, Maine Medical Center Cancer Institute, Maine Medical Center, Scarborough, ME

Research Funding

No funding sources reported

Background: Quality end-of-life cancer care involves a shift from aggressive therapy to supportive services.   Reasons for variations in intensity of late-life cancer care are incompletely understood.  The goal of this work was to examine intensity of care based on principal healthcare provider in the last month of life, comparing primary care providers (PCPs) with oncology specialists. Methods:  A retrospective claims-based analysis of hospitalizations, emergency department (ED) visits, intensive care unit admissions in the last 30 days of life; in-hospital deaths; terminal chemotherapy; and under-use/late hospice referrals among a 20% sample (n=235,821) of Medicare beneficiaries dying with poor-prognosis cancers. Logistic regression was used to quantify care variations comparing PCPs with oncology specialists as well as combined care by PCPs and oncology specialists Results: Among the 235,821 individuals studied, mean age at death was 78 years, 51.4% were male, 90.8% were non-black race, 73.5% lived in urban areas, and median income was $46,634.  Of these, 74% received care from a PCP and/or an oncology specialist in the last month of life.  Data (expressed as %) comparing the full cohort with those principally cared for by PCPs versus by oncology specialists versus combined care by PCPs and oncology specialists follow. Conclusions:  Most measures of care intensity fell outside published benchmarks, signifying overly aggressive care.  Intensity of late-life care among cancer-affected seniors varies significantly by principal healthcare provider with the most intensive care shown among those receiving combined care from PCPs and oncology specialists.


All patients  Primary care (PCP) only  Oncology specialist only  PCP and oncology
n= 235,821 100,766 (42.7%) 33,318 (14.1%) 39,554 (16.8%)

More than 1 hospitalization 10.2 12.4 8.5 18.3
More than 1 ED visit 10.2 13.5 6.2 17.2
Admitted to ICU 23.7 29.2 18.1 31.3
Died in an acute care facility 28.8 30.3 31.1 37.8
Chemotherapy within 14 days of death 6.0 1.6 16.4 15.9
Chemotherapy within 30 days of death 12.5 3.7 34.2 31.4
No hospice services within 6 months of death 44.8 50.6 43.2 54.6
Admitted to hospice within 3 days of death 15.1 18.3 17.3 27.4

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2011 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Patient and Survivor Care

Track

Patient and Survivor Care

Sub Track

End-of-Life Care

Citation

J Clin Oncol 29: 2011 (suppl; abstr 9132)

Abstract #

9132

Poster Bd #

53C

Abstract Disclosures

Similar Abstracts

Abstract

2024 ASCO Quality Care Symposium

Systemic anti-cancer treatment and healthcare utilization at end of life: A SEER Medicare analysis.

First Author: Kerin B. Adelson

Abstract

2021 ASCO Quality Care Symposium

Hospitalization burden and end-of-life (EOL) care in elderly patients with glioblastoma (GBM).

First Author: Laura Donovan

First Author: Amy An